Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2012 Jun;10(6):631-5.
doi: 10.1586/eri.12.43.

Diagnosis of extrapulmonary tuberculosis using the Xpert(®) MTB/RIF assay

Stephen D Lawn  1 , Alimuddin I Zumla
Affiliations
Comment

Diagnosis of extrapulmonary tuberculosis using the Xpert(®) MTB/RIF assay

Stephen D Lawn et al. Expert Rev Anti Infect Ther. 2012 Jun.

Abstract

Evaluation of: Tortoli E, Russo C, Piersimoni C et al. Clinical validation of Xpert MTB/RIF for the diagnosis of extrapulmonary tuberculosis. Eur. Respir. J. doi:10.1183/09031936.00176311 (2012) (Epub ahead of print). The Xpert® MTB/RIF assay has been CE-marked for rapid molecular diagnosis of TB in Europe and has been endorsed by the WHO as a replacement for sputum smear microscopy for diagnosis of pulmonary TB in low- and middle-income countries. However, few data are available to inform recommendations for use of the assay for testing nonsputum clinical samples when investigating suspected extrapulmonary TB (EPTB). We review and discuss the findings of Tortoli and colleagues, who evaluated the assay used for this purpose in a large study of adults and children in Italy. They provide a per-sample analysis of 268 diagnoses of EPTB at a range of anatomic sites (sensitivity: 81.3%; 95% CI: 76.2-85.8) and data for 1206 samples in which EPTB was excluded (specificity: 99.8%; 95% CI: 99.4-100). We discuss how this paper forms an important addition to the growing body of literature demonstrating the utility of Xpert MTB/RIF for EPTB diagnosis when applied to diverse types of clinical samples

PubMed Disclaimer

Comment on

References

    1. Lawn SD, Zumla AI. Tuberculosis. Lancet. 2011;378:57–72. - PubMed
    1. Centers for Disease Control and Prevention Updated guidelines for the use of nucleic acid amplification tests in the diagnosis of tuberculosis. MMWR Morb. Mortal. Wkly Rep. 2009;58:7–10. - PubMed
    1. Lawn SD, Nicol MP. Xpert(R) MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance. Future Microbiol. 2011;6:1067–1082. - PMC - PubMed
    1. Boehme CC, Nabeta P, Hillemann D, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N. Engl. J. Med. 2010;363:1005–1015. - PMC - PubMed
    1. Tortoli E, Russo C, Piersimoni C, et al. Clinical validation of Xpert MTB/RIF for the diagnosis of extrapulmonary tuberculosis. Eur. Respir. J. 2012 doi:10.1183/09031936.00176311. (Epub ahead of print) - PubMed

Website

    1. WHO Tuberculosis diagnostics automated DNA test. www.who.int/tb/features_archive/xpert_factsheet.pdf.